Sotera Health Co (SHC)

Official site

HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

$16.01

+0.14 (+0.88%)

Market Cap: $4.53B

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

88%(22/25)

Avg Surprise

+6.97%

Streak

8 Q

Upcoming Estimates

Period ending Dec 31, 2026

EPS Consensus$0.30

Range$0.30 - $0.31

10 analysts

Revenue Consensus

$347M

Range$342M - $350M

9 analysts

Last 12 of 31 reported quarters and 1 upcoming estimate

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.30	$0.30 - $0.31	-	-	10	-	-
Sep 30, 2026Sep 26 Reported Nov 3, 2026Reported Nov 3	$0.27	$0.24	$0.23 - $0.24	+12.50%	Beat	10	1 0 30d	+3.8%
Jun 30, 2026Jun 26 Reported Aug 6, 2026Reported Aug 6	$0.24	$0.22	$0.21 - $0.23	+9.09%	Beat	10	0 2 30d	+20.0%
Mar 31, 2026Mar 26 Reported May 5, 2026Reported May 5	$0.18	$0.17	$0.15 - $0.18	+5.88%	Beat	10	0 1 30d	+28.6%
Dec 31, 2025Dec 25 Reported Feb 24, 2026Reported Feb 24	$0.26	$0.24	$0.24 - $0.25	+7.35%	Beat	10	6 0 30d	+23.8%
Sep 30, 2025Sep 25 Reported Nov 4, 2025Reported Nov 4	$0.26	$0.22	$0.21 - $0.22	+18.18%	Beat	7	1 0 30d	+52.9%
Jun 30, 2025Jun 25 Reported Aug 8, 2025Reported Aug 8	$0.20	$0.17	$0.17 - $0.18	+17.65%	Beat	7	0 8 30d	+5.3%
Mar 31, 2025Mar 25 Reported May 1, 2025Reported May 1	$0.14	$0.12	$0.11 - $0.13	+16.67%	Beat	8	0 1 30d	+7.7%
Dec 31, 2024Dec 24 Reported Feb 27, 2025Reported Feb 27	$0.21	$0.20	$0.19 - $0.21	+4.01%	Beat	8	1 1 30d	-19.2%
Sep 30, 2024Sep 24 Reported Nov 5, 2024Reported Nov 5	$0.17	$0.18	$0.18 - $0.19	-5.56%	Miss	8	1 0 30d	-19.0%
Jun 30, 2024Jun 24 Reported Aug 5, 2024Reported Aug 5	$0.19	$0.16	$0.16 - $0.17	+18.75%	Beat	8	No revisions (30d)	-9.5%
Mar 31, 2024Mar 24 Reported May 2, 2024Reported May 2	$0.13	$0.12	$0.11 - $0.15	+8.33%	Beat	7	0 1 30d	+0.0%
Dec 31, 2023Dec 23 Reported Feb 27, 2024Reported Feb 27	$0.26	$0.26	$0.24 - $0.28	+0.00%	Beat	7	1 0 30d	+4.0%

Key Metrics

Valuation
P/E Ratio	16.85	EV/EBITDA	11.71x
Price/FCF	33.81x	FCF Yield	2.96%
Profitability
Profit Margin	14.10%	Operating Margin	39.80%
ROE	27.00%	ROIC	8.96%
Financial Health
Debt/Equity	3.10x	Interest Coverage	208.41x
Current Ratio	3.13x	Quick Ratio	2.91x
Trading Statistics
Beta	1.93	Avg Volume	2.49M
52-Week High	$19.85	52-Week Low	$13.09

Technical Indicators Dashboard

Moving Averages

SMA 10$17.44

SMA 20$17.70

SMA 50$18.22

SMA 200$16.94

EMA 10$17.01

EMA 20$17.50

EMA 50$17.92

EMA 200$17.19

MACD

Line: -0.50Signal: -0.26Hist: -0.25

ADX

ADX: 21.7+DI: 10.8-DI: 35.5

Aroon & PSAR

Aroon Up8.0

Aroon Down100.0

PSAR$18.52

Bollinger Bands

Upper Band$19.48

Lower Band$15.93

%B Position2005%(Upper)

Band Width0.02

RSI (14-Day)

Neutral

31.2

Momentum Oscillators

Stoch %K9.5

Stoch %D9.6

Williams %R-89.0

ROC (10d)-11.5%

Momentum-2.09

CCI (20d)-199.4

MFI (14d)39.4

Volatility Measures

ATR (14d)$0.62(3.9%)

StdDev (20d)0.89

Hist Vol43.3%(High)

Volume Flow

VWAP$15.90

OBV-1.7M

AD Line20.0M

CMF (20d)-0.132

Volume Metrics

Avg Vol (20d)2.5M

Vol Ratio0.9x

VWMA (20d)$17.50

Pivot Points

R3$17.25

R2$16.96

R1$16.41

Pivot Point$16.12

S1$15.57

S2$15.28

S3$14.73

Advanced Oscillators

TSI-25.03

Ultimate Osc29.5

KST-45.30

Financial Data

Quarter	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Revenue	$324.89M	$321.38M	$280.05M	$303.44M	$311.31M	$294.34M	$254.52M	$290.20M	$285.47M	$276.59M	$248.18M	$310.24M
Cost of Revenue	$144.10M	$143.41M	$132.98M	$137.52M	$133.75M	$127.72M	$119.09M	$125.84M	$127.44M	$123.80M	$121.06M	$130.16M
Gross Profit	$180.79M	$177.96M	$147.07M	$165.92M	$177.56M	$166.62M	$135.43M	$164.37M	$158.02M	$152.79M	$127.11M	$180.08M

Operating Expenses	$67.14M	$71.17M	$71.24M	$-4,406,000	$66.38M	$78.19M	$78.39M	$77.22M	$77.52M	$75.99M	$73.94M	$76.06M
R&D	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
SG&A	$64.14M	$68.16M	$68.21M	$57.51M	$63.29M	$68.89M	$63.06M	$61.84M	$62.01M	$60.58M	$58.21M	$60.36M
Operating Income	$113.64M	$106.79M	$75.83M	$170.33M	$111.18M	$88.43M	$57.04M	$87.15M	$80.51M	$76.80M	$53.17M	$104.02M

Interest Income	$-34,122,000	$-34,405,000	$-34,745,000	$-35,048,000	$-39,147,000	$-40,651,000	$-40,876,000	$-40,960,000	$-41,572,000	$-40,388,000	$-41,771,000	$-42,653,000
Interest Expense	$0	$936,000	$33.21M	$99.83M	$1.09M	$80,000	$71.87M	$42.18M	$70,000	$23.40M	$42.16M	$38.35M
Income Before Tax	$83.73M	$78.05M	$42.61M	$70.50M	$72.94M	$18.90M	$-14,823,000	$44.96M	$42.75M	$15.14M	$11.01M	$65.67M
Income Tax Expense	$25.34M	$24.41M	$16.02M	$35.65M	$24.54M	$10.94M	$-1,563,000	$32.64M	$25.76M	$6.39M	$4.69M	$26.99M

Net Income	$58.39M	$53.64M	$26.59M	$34.85M	$48.40M	$7.96M	$-13,260,000	$12.32M	$17.00M	$8.75M	$6.32M	$38.68M

EBITDA	$151.90M	$148.42M	$109.64M	$139.85M	$142.83M	$96.02M	$68.13M	$128.21M	$128.72M	$120.93M	$95.75M	$151.57M
EBIT	$117.85M	$113.39M	$77.36M	$105.84M	$113.17M	$59.63M	$26.05M	$86.62M	$84.40M	$78.93M	$52.78M	$108.32M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about SHC

News

Sotera Health (SHC) Stock May Look Stretched After Raised Guidance

Sotera Health's shares have recently slipped despite positive earnings, raising questions about whether its current price of US$15.87 is justified by its profitability. While the company's P/E ratio of 26.1x is below...

Simply Wall St•Nov 6, 2026 1:30 AM ET11/6/26•Somewhat-Bearish

Barclays maintains Sotera Health at Overweight, lowers price target to $20 from $22

Barclays has reiterated its "Overweight" rating for Sotera Health (SHC) but has reduced its price target from $22 to $20, representing a 9.1% decrease. Despite the lower target...

TradingView•Nov 4, 2026 2:11 PM ET11/4/26•Somewhat-Bearish

Sotera Health’s Free Cash Flow Story Runs Through 2027

RBC has given Sotera Health a vote of confidence, predicting a significant jump in the company's free cash flow in 2027. This anticipated increase is due to the winding down of heavy capital expenditures related...

Finimize•Nov 4, 2026 12:11 PM ET11/4/26•Bullish

Sotera Health Releases Q3 2026 Financial Results

Sotera Health Company (SHC) announced third-quarter results for 2026, exceeding Wall Street expectations with adjusted earnings of $0.29 per share...

AlphaStreet•Nov 3, 2026 2:41 PM ET11/3/26•Bullish

Sotera Health Q3 2026 Earnings Call Transcript

Sotera Health reported solid third-quarter 2026 financial results, with revenues increasing 4.4% to $325 million and adjusted EBITDA up 3.9% to $171 million. The company reaffirmed its full-year 2026 outlook for constant...

Benzinga•Nov 3, 2026 9:41 AM ET11/3/26•Somewhat-Bullish

SHC Valuation and Fair Value

P/E: 16.9x
Forward P/E: 15.9x
EV/EBITDA: 11.7x
P/FCF: 33.8x
PEG: 1.3x
P/B: 6.2x

See GNG's fair value

SHC Profitability: Margins, ROIC and FCF

Gross margin: 54.6%
Operating margin: 39.8%
Net margin: 14.1%
ROIC: 9.0%
ROE: 27.0%
FCF margin: 11.0%
FCF yield: 3.0%

SHC Competitors

Company	Ticker
Dianthus Therapeutics Inc.	DNTH
Heartflow, Inc. Common Stock	HTFL
Amicus Therapeutics Inc	FOLD
CareDx Inc	CDNA
Erasca Inc	ERAS
Akero Therapeutics Inc	AKRO
Travere Therapeutics Inc	TVTX
iRhythm Technologies Inc	IRTC

Sector: Healthcare

SHC Analyst Ratings

Consensus: Buy
Analysts: 10
Strong Buy: 3
Buy: 5
Hold: 1
Sell: 0
Strong Sell: 1

SHC Bull Case vs Bear Case

Bull case

SHC beat EPS estimates in 100.0% of its last 8 reported quarters.
80.0% of SHC's analyst ratings are Buy or Strong Buy.

Bear case

SHC has a debt-to-equity ratio of 3.1x.

SHC Earnings: Beat Rate and Next Report

Beat rate: 8 of 8 quarters (100.0%)
Average surprise: 11.4%
EPS estimate (fiscal period ending Dec 31, 2026): $0.30

SHC Earnings Date

SHC reports Feb 22, 2027, before the open. The date is estimated.

SHC Earnings Call

The latest SHC earnings call transcript on file is labeled 2026Q3.

Read the 2026Q3 transcript

SHC ETF Holders

GNG tracks 8 ETFs that hold SHC. The largest weights:

S&P MidCap 400 ETF (MDY), 0.16% of the fund
Vanguard Morningstar Small-Cap Growth ETF (VBK), 0.14% of the fund
iShares U.S. Healthcare ETF (IYH), 0.08% of the fund
Vanguard Health Care Index Fund ETF Shares (VHT), 0.07% of the fund
Fidelity Mid Cap Index Fund (FSMDX), 0.03% of the fund

Open the ETF Stock Exposure tool for SHC

See insider activity

Frequently Asked Questions About SHC

When does SHC report earnings?

Sotera Health Co (SHC) is expected to report earnings on Feb 22, 2027.

Does SHC pay dividends?

Sotera Health Co (SHC) does not currently pay a regular dividend.

What is SHC's P/E ratio?

Sotera Health Co has a price-to-earnings (P/E) ratio of 16.85.

What is SHC's market cap?

Sotera Health Co (SHC) has a market capitalization of $4.53B with a current stock price of $16.01.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In